Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Rodger

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
British Journal of Haematology|July 25, 2022
Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysisJameel Abdulrehman, Carolyne Elbaz, David Aziz, et al.
The New England Journal of Medicine|February 22, 2018
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee ArthroplastyDavid R Anderson, Michael Dunbar, John Murnaghan, et al.
Lancet (London, England)|December 10, 2013
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trialSusan R Kahn, Stan Shapiro, Philip S Wells, et al.
Annals of Internal Medicine|November 22, 2021
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort StudyGrégoire Le Gal, Michael J Kovacs, Laurent Bertoletti, et al.
Thrombosis and Haemostasis|November 9, 2021
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysisFaizan Khan, Alvi Rahman, Tobias Tritschler, et al.
Lancet (London, England)|July 29, 2014
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trialMarc A Rodger, William M Hague, John Kingdom, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesGaëlle Munsch, Florian Thibord, Ohanna C Bezerra, et al.
Blood|August 14, 2025
Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesGaëlle Munsch, Florian Thibord, Ohanna C Bezerra, et al.
Annals of Internal Medicine|September 13, 2021
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysisFaizan Khan, Tobias Tritschler, Miriam Kimpton, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
British Journal of Haematology|July 25, 2022
Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysisJameel Abdulrehman, Carolyne Elbaz, David Aziz, et al.
The New England Journal of Medicine|February 22, 2018
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee ArthroplastyDavid R Anderson, Michael Dunbar, John Murnaghan, et al.
Lancet (London, England)|December 10, 2013
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trialSusan R Kahn, Stan Shapiro, Philip S Wells, et al.
Annals of Internal Medicine|November 22, 2021
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort StudyGrégoire Le Gal, Michael J Kovacs, Laurent Bertoletti, et al.
Thrombosis and Haemostasis|November 9, 2021
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysisFaizan Khan, Alvi Rahman, Tobias Tritschler, et al.
Lancet (London, England)|July 29, 2014
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trialMarc A Rodger, William M Hague, John Kingdom, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesGaëlle Munsch, Florian Thibord, Ohanna C Bezerra, et al.
Blood|August 14, 2025
Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesGaëlle Munsch, Florian Thibord, Ohanna C Bezerra, et al.
Annals of Internal Medicine|September 13, 2021
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysisFaizan Khan, Tobias Tritschler, Miriam Kimpton, et al.
Pageof 11